{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T20:12:58Z","timestamp":1762200778791,"version":"build-2065373602"},"reference-count":5,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2017,2,2]],"date-time":"2017-02-02T00:00:00Z","timestamp":1485993600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J American Geriatrics Society"],"published-print":{"date-parts":[[2017,5]]},"abstract":"<jats:p>Clinicians are aware of the risks and benefits of metformin in type 2 diabetes. In geriatric populations lactic acidosis due to diminishing kidney function is an issue. The recent addition of a group of agents to control diabetes through increased glycosuria may increase the risk of dehydration and acidosis. This may happen due to gastrointestinal loss from metformin diarrhea or urine loss from diuretics. A typical example is presented.<\/jats:p>","DOI":"10.1111\/jgs.14724","type":"journal-article","created":{"date-parts":[[2017,2,2]],"date-time":"2017-02-02T11:54:17Z","timestamp":1486036457000},"source":"Crossref","is-referenced-by-count":5,"title":["Metformin\u2010SGLT2, Dehydration, and Acidosis Potential"],"prefix":"10.1111","volume":"65","author":[{"given":"John A.","family":"D'Elia","sequence":"first","affiliation":[{"name":"Kidney and Hypertension Section Joslin Diabetes Center Harvard Medical School Boston Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alissa R.","family":"Segal","sequence":"additional","affiliation":[{"name":"Kidney and Hypertension Section Joslin Diabetes Center Harvard Medical School Boston Massachusetts"},{"name":"Department of Pharmacy Practice MCPHS University Boston Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larry A.","family":"Weinrauch","sequence":"additional","affiliation":[{"name":"Kidney and Hypertension Section Joslin Diabetes Center Harvard Medical School Boston Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2017,2,2]]},"reference":[{"key":"e_1_2_3_2_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2015.04.001"},{"key":"e_1_2_3_3_1","unstructured":"FDA Drug Safety Communication: FDA revises warnings regarding use of the diabetes medicine metformin in certain patients with reduced kidney function.2016."},{"key":"e_1_2_3_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2015.12.021"},{"key":"e_1_2_3_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/jch.12776"},{"key":"e_1_2_3_6_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc16-0041"}],"container-title":["Journal of the American Geriatrics Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjgs.14724","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/agsjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jgs.14724","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T19:56:11Z","timestamp":1762199771000},"score":1,"resource":{"primary":{"URL":"https:\/\/agsjournals.onlinelibrary.wiley.com\/doi\/10.1111\/jgs.14724"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,2]]},"references-count":5,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["10.1111\/jgs.14724"],"URL":"https:\/\/doi.org\/10.1111\/jgs.14724","archive":["Portico"],"relation":{},"ISSN":["0002-8614","1532-5415"],"issn-type":[{"type":"print","value":"0002-8614"},{"type":"electronic","value":"1532-5415"}],"subject":[],"published":{"date-parts":[[2017,2,2]]}}}